Clinical data | |
---|---|
Routes of administration | N/A |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C22H30Cl2N2O2 |
Molar mass | 425.39 g·mol−1 |
3D model ( JSmol) | |
| |
| |
NY (what is this?) (verify) |
Spiradoline (U-62066) is a drug which acts as a highly selective κ-opioid agonist. [1] It has analgesic, [2] diuretic, [3] and antitussive effects, [4] and produces subjective effects in animals similar to those of ketazocine and alazocine. [5] The main effect in humans is sedation, along with analgesic and diuretic effects, but significant side effects such as dysphoria and hallucinations have stopped it from being used clinically. [6]
μ-opioid (MOR) |
| ||||
---|---|---|---|---|---|
δ-opioid (DOR) |
| ||||
κ-opioid (KOR) |
| ||||
Nociceptin (NOP) |
| ||||
Others |
|
This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
Clinical data | |
---|---|
Routes of administration | N/A |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C22H30Cl2N2O2 |
Molar mass | 425.39 g·mol−1 |
3D model ( JSmol) | |
| |
| |
NY (what is this?) (verify) |
Spiradoline (U-62066) is a drug which acts as a highly selective κ-opioid agonist. [1] It has analgesic, [2] diuretic, [3] and antitussive effects, [4] and produces subjective effects in animals similar to those of ketazocine and alazocine. [5] The main effect in humans is sedation, along with analgesic and diuretic effects, but significant side effects such as dysphoria and hallucinations have stopped it from being used clinically. [6]
Psychedelics ( 5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives ( NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants ( mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
μ-opioid (MOR) |
| ||||
---|---|---|---|---|---|
δ-opioid (DOR) |
| ||||
κ-opioid (KOR) |
| ||||
Nociceptin (NOP) |
| ||||
Others |
|
This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |